CLASS I ONGOING Drug recall · Reported 11 Feb 2026 · FDA Enforcement Report
Rheumacare capsules, Mfg in India by: Virgo UAP Pharma Pvt recalled
Handelnine Global is recalling Rheumacare capsules, Mfg in India by: Virgo UAP Pharma Pvt, distributed in New York. The recall was initiated on 22 Dec 2025 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0332-2026
- FDA event ID
- 98165
- Recalling firm
- Handelnine Global, South Plainfield, NJ
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- 22 Dec 2025
- FDA classified
- 12 Feb 2026
- Reported
- 11 Feb 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Lead & Heavy Metals
Timeline
| 22 Dec 2025 | Recall initiated by company | |
| 11 Feb 2026 | Published in enforcement report | +51 days |
| 12 Feb 2026 | Classified by FDA | +1 day |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: product found to contain lead.
Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.
Product as listed by the FDA
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Where it was distributed
Product was distributed to one customer in NY.
Questions about this recall
Why was it recalled?
CGMP Deviations: product found to contain lead.
Which lots are affected?
Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Where was it sold?
Product was distributed to one customer in NY.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.